New drugs for treating small cell lung cancer
Open Access
- 30 June 1995
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 12, S53-S61
- https://doi.org/10.1016/s0169-5002(10)80018-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC)Annals of Oncology, 1994
- Cancer statistics, 1994CA: A Cancer Journal for Clinicians, 1994
- Taxotere is active in small cell lung cancer (SCLC) a phase II trial of the eortc early clinical trials group (ECTG)European Journal Of Cancer, 1993
- The Current Status of Camptothecin Analogues as Antitumor AgentsJNCI Journal of the National Cancer Institute, 1993
- A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.Journal of Clinical Oncology, 1991
- Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of TaxolJNCI Journal of the National Cancer Institute, 1991
- Synthesis of water-soluble (aminoalkyl)camptothecin analogs: inhibition of topoisomerase I and antitumor activityJournal of Medicinal Chemistry, 1991
- Taxol binds to polymerized tubulin in vitroThe Journal of cell biology, 1981
- Promotion of microtubule assembly in vitro by taxolNature, 1979
- Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifoliaJournal of the American Chemical Society, 1971